XNAS 08 Jul, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Carl S. Goldfischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 1,440 | 1,440 | - | - | Stock Option (right to buy) | |
| David Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 720 | 720 | - | - | Stock Option (right to buy) | |
| Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 720 | 720 | - | - | Stock Option (right to buy) | |
| Jayson Dallas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 720 | 720 | - | - | Stock Option (right to buy) | |
| Amy B. Wechsler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 720 | 720 | - | - | Stock Option (right to buy) | |
| Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 720 | 720 | - | - | Stock Option (right to buy) | |
| Garrett Winslow | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 1,320 | 1,480 | - | - | Common Stock | |
| Garrett Winslow | General Counsel | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 03 Jan 2025 | 471 | 1,009 | - | 5.6 | 2,638 | Common Stock |
| Garrett Winslow | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 1,320 | 2,680 | - | - | Restricted Stock Units | |
| Garrett Winslow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Hans T. Schambye | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 16,400 | 16,400 | - | - | Stock Option (right to buy) | |
| Hans T. Schambye | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 2,640 | 4,738 | - | - | Common Stock | |
| Hans T. Schambye | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 03 Jan 2025 | 1,341 | 3,397 | - | 5.6 | 7,510 | Common Stock |
| Hans T. Schambye | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 2,640 | 5,360 | - | - | Restricted Stock Units | |
| Matthew Kronmiller | EVP Strategy and CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Lori Firmani | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Lori Firmani | Interim CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 726 | 1,474 | - | - | Restricted Stock Units | |
| Lori Firmani | Interim CFO | Sale of securities on an exchange or to another person at price $ 5.63 per share. | 03 Jan 2025 | 261 | 465 | - | 5.6 | 1,469 | Common Stock |
| Lori Firmani | Interim CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 726 | 726 | - | - | Common Stock | |
| Schambye Hans T. | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 44,100 | 44,100 | - | - | Stock Option (right to buy) | |
| Kronmiller Matthew | EVP Strategy and CBO | 09 Oct 2024 | 8,600 | 8,600 | - | - | Stock Option (right to buy) | ||
| Winslow Garrett | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (right to buy) | |
| David Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Carl S. Goldfischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Jayson Dallas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Garrett Winslow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 100,000 | 100,000 | - | - | Restricted Stock Units | |
| T. Schambye Hans | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 200,000 | 200,000 | - | - | Restricted Stock Units | |
| Freve Jonathan | Chief Financial Officer | 03 Jan 2024 | 100,000 | 100,000 | - | - | Restricted Stock Units | ||
| Carl S. Goldfischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| David Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Chau Q. Khuong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Jayson Dallas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Jonathan Freve | Chief Financial Officer | 04 Jan 2023 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | ||
| Bertil Lindmark | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | |
| Garrett Winslow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Hans T. Schambye | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Anders Pedersen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 115,000 | 115,000 | - | - | Stock Option (right to buy) | |
| Stephanie Oestreich | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Carl S. Goldfischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| David Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Chau Q. Khuong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,000 | 18,000 | - | - | /s/ Jonathan Freve, attorney-in-fact | |
| Jayson Dallas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Bertil Lindmark | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.16 per share. | 22 Mar 2022 | 14,604 | 16,604 | - | 2.2 | 31,545 | Common Stock |
| Hans T. Schambye | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.15 per share. | 22 Mar 2022 | 5,000 | 52,428 | - | 2.2 | 10,750 | Common Stock |
| Stephanie Oestreich | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | |
| Jonathan Freve | Chief Financial Officer | 04 Jan 2022 | 118,750 | 118,750 | - | - | Stock Option (right to buy) | ||
| Bertil Lindmark | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 118,750 | 118,750 | - | - | Stock Option (right to buy) | |
| Hans T. Schambye | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 287,500 | 287,500 | - | - | Stock Option (right to buy) | |
| Anders Pedersen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 118,750 | 118,750 | - | - | Stock Option (right to buy) | |
| Jonathan Freve | Chief Financial Officer | 03 Dec 2021 | 4,000 | 12,000 | - | 2.5 | 9,960 | Common Stock | |
| Carl S. Goldfischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Chau Q. Khuong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 9,000 | 9,000 | - | - | Stock Option (right to buy) | |
| Hans T. Schambye | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 09 Nov 2021 | 4,500 | 47,428 | - | 3.5 | 15,750 | Common Stock |
| Jonathan Freve | Chief Financial Officer | 08 Nov 2021 | 3,000 | 8,000 | - | 3.4 | 10,200 | Common Stock | |
| Jonathan Freve | Chief Financial Officer | 18 Aug 2021 | 3,000 | 5,000 | - | 3.9 | 11,760 | Common Stock | |
| Bertil Lindmark | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 5.26 per share. | 28 Jun 2021 | 2,000 | 2,000 | - | 5.3 | 10,520 | Common Stock |
| Hans T. Schambye | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.11 per share. | 24 Jun 2021 | 3,000 | 42,928 | - | 5.1 | 15,330 | Common Stock |
| Jonathan Freve | Chief Financial Officer | 23 Jun 2021 | 2,000 | 2,000 | - | 4.7 | 9,480 | Common Stock | |
| Carl S. Goldfischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Chau Q. Khuong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Jayson Dallas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Anne Prener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Jonathan Freve | Chief Financial Officer | 05 Jan 2021 | 95,000 | 95,000 | - | - | Stock Option (right to buy) | ||
| Bertil Lindmark | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 95,000 | 95,000 | - | - | Stock Option (right to buy) | |
| Hans T. Schambye | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 230,000 | 230,000 | - | - | Stock Option (right to buy) | |
| Anders Pedersen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Carl S. Goldfischer | Director | 02 Nov 2020 | 9,587 | 9,587 | - | - | Common Stock | ||
| Carl S. Goldfischer | Director | 02 Nov 2020 | 3,688 | 0 | - | - | Series D Preferred Stock | ||
| Carl S. Goldfischer | Director | 02 Nov 2020 | 7,475 | 0 | - | - | Series C-3 Preferred Stock | ||
| Carl S. Goldfischer | Director | 02 Nov 2020 | 392,367 | 0 | - | - | Series C-3 Preferred Stock | ||
| Carl S. Goldfischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 3,688 | 3,688 | - | - | Series D Preferred Stock | |
| Carl S. Goldfischer | Director | 02 Nov 2020 | 19,432 | 19,432 | - | - | Common Stock | ||
| Carl S. Goldfischer | Director | 02 Nov 2020 | 1,020,036 | 1,020,036 | - | - | Common Stock | ||
| Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 109,187 | 109,187 | - | - | Stock Option (right to buy) | |
| Amit D. Munshi | Director | 02 Nov 2020 | 4,793 | 4,793 | - | - | Common Stock | ||
| Amit D. Munshi | Director | 02 Nov 2020 | 1,844 | 0 | - | - | Series D Preferred Stock | ||
| Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 1,844 | 1,844 | - | - | Series D Preferred Stock | |
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 272,533 | 0 | - | - | Series C-4 Preferred Stock | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 116,800 | 0 | - | - | Series C-2 Preferred Stock | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 291,999 | 0 | - | - | Series C-2 Preferred Stock | ||
| Chau Q. Khuong | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 73,773 | 73,773 | - | - | Series D Preferred Stock | |
| Chau Q. Khuong | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 59,350 | 59,350 | - | - | Series D Preferred Stock | |
| Chau Q. Khuong | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 148,395 | 148,395 | - | - | Series D Preferred Stock | |
| Chau Q. Khuong | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 02 Nov 2020 | 209,500 | 1,031,811 | - | 15 | 3,142,500 | Common Shares |
| Chau Q. Khuong | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 02 Nov 2020 | 523,833 | 2,579,657 | - | 15 | 7,857,495 | Common Shares |
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 191,787 | 191,787 | - | - | Common Shares | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 822,311 | 822,311 | - | - | Common Shares | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 2,055,824 | 2,055,824 | - | - | Common Shares | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 73,773 | 0 | - | - | Series D Preferred Stock | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 148,395 | 0 | - | - | Series D Preferred Stock | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 59,350 | 0 | - | - | Series D Preferred Stock | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 31,147 | 0 | - | - | Series C-5 Preferred Stock | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 77,866 | 0 | - | - | Series C-5 Preferred Stock | ||
| Chau Q. Khuong | Director, Ten Percent Owner | 02 Nov 2020 | 109,013 | 0 | - | - | Series C-4 Preferred Stock | ||
| Hans T. Schambye | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 519,940 | 519,940 | - | - | Stock Option (right to buy) | |
| Hans T. Schambye | Director, Chief Executive Officer | 02 Nov 2020 | 13,931 | 39,928 | - | - | Common Stock | ||
| Hans T. Schambye | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 207,976 | 207,976 | - | - | Stock Option (right to buy) | |
| Hans T. Schambye | Director, Chief Executive Officer | 02 Nov 2020 | 5,359 | 0 | - | - | Series C-1 Preferred Stock | ||
| Anders Pedersen | Chief Operating Officer | 02 Nov 2020 | 3,746 | 3,746 | - | - | Common Stock | ||
| Anders Pedersen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 142,983 | 142,983 | - | - | Stock Option (right to buy) | |
| Anders Pedersen | Chief Operating Officer | 02 Nov 2020 | 1,441 | 0 | - | - | Series C-1 Preferred Stock | ||
| Anders Pedersen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2020 | 77,991 | 77,991 | - | - | Stock Option (right to buy) |